Malin Corporation | MLC - Current Liabilities

Stock Price
7.60
Daily Change
0 0%
Monthly
-5.00%
Yearly
-22.05%
Q1 Forecast
7.37

Malin Corporation reported EUR1000K in Current Liabilities for its fiscal semester ending in December of 2024.





Current Liabilities Change Date
Akebia Therapeutics USD 133.38M 14.66M Sep/2025
Alaunos Therapeutics USD 921K 153K Sep/2025
ALKERMES USD 474.36M 31.6M Sep/2025
Avita Medical AUD 62.6M 42.44M Jun/2025
Dianthus Therapeutics USD 23.86M 3.76M Sep/2025
Eurofins Scientific SE EUR 2.43B 344.6M Dec/2025
Ionis Pharmaceuticals USD 903.46M 6.22M Sep/2025
IQVIA Holdings USD 8.34B 170M Dec/2025
Lonza CHF 3.58B 970M Dec/2024
Malin Corporation EUR 1000K 500K Dec/2024
Moderna USD 1.99B 306M Dec/2025
Organon & Co USD 2.68B 117M Sep/2025
Ovoca Bio EUR 2.44M 1.1M Jun/2022
Revvity USD 1.33B 108.5M Dec/2025
Tectonic Therapeutic USD 9.37M 1.99M Sep/2025
Viatris USD 7.36B 230.7M Sep/2025
Xeris Pharmaceuticals USD 116.2M 21.03M Sep/2025